Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominik Sturm

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica|August 20, 2016
Evidence of H3 K27M mutations in posterior fossa ependymomasMarco Gessi, David Capper, Felix Sahm, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 17, 2013
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastomaMarc Remke, Esther Hering, Nicolas U Gerber, et al.
Neuro-Oncology|April 5, 2024
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatmentDenise Obrecht-Sturm, Lena Schömig, Martin Mynarek, et al.
Acta Neuropathologica|June 6, 2022
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastomaSebastian Adeberg, Maximilian Knoll, Christian Koelsche, et al.
Brain Pathology (Zurich, Switzerland)|October 10, 2017
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysisAndrey Korshunov, Lukas Chavez, Tanvi Sharma, et al.
Neuro-Oncology|October 11, 2017
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor locationMichael Karremann, Gerrit H Gielen, Marion Hoffmann, et al.
Acta Neuropathologica|September 7, 2022
Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinasesPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology Advances|August 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a <i>PDGFRA</i> inhibitor trialTom T Fischer, Kendra K Maass, Melanie Schoof, et al.
Acta Neuropathologica|March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersAndrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Acta Neuropathologica|April 5, 2019
Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1Christian Thomas, Friederike Knerlich-Lukoschus, Harald Reinhard, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica|August 20, 2016
Evidence of H3 K27M mutations in posterior fossa ependymomasMarco Gessi, David Capper, Felix Sahm, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|May 17, 2013
Somatostatin receptor subtype 2 (sst₂) is a potential prognostic marker and a therapeutic target in medulloblastomaMarc Remke, Esther Hering, Nicolas U Gerber, et al.
Neuro-Oncology|April 5, 2024
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatmentDenise Obrecht-Sturm, Lena Schömig, Martin Mynarek, et al.
Acta Neuropathologica|June 6, 2022
DNA-methylome-assisted classification of patients with poor prognostic subventricular zone associated IDH-wildtype glioblastomaSebastian Adeberg, Maximilian Knoll, Christian Koelsche, et al.
Brain Pathology (Zurich, Switzerland)|October 10, 2017
Epithelioid glioblastomas stratify into established diagnostic subsets upon integrated molecular analysisAndrey Korshunov, Lukas Chavez, Tanvi Sharma, et al.
Neuro-Oncology|October 11, 2017
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor locationMichael Karremann, Gerrit H Gielen, Marion Hoffmann, et al.
Acta Neuropathologica|September 7, 2022
Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinasesPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology Advances|August 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a <i>PDGFRA</i> inhibitor trialTom T Fischer, Kendra K Maass, Melanie Schoof, et al.
Acta Neuropathologica|March 11, 2015
Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markersAndrey Korshunov, Marina Ryzhova, Volker Hovestadt, et al.
Acta Neuropathologica|April 5, 2019
Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1Christian Thomas, Friederike Knerlich-Lukoschus, Harald Reinhard, et al.
Pageof 13